These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17243849)

  • 1. Adherence to the components of the Fleetwood model: self-reported process measures in the Fleetwood Phase III study.
    Lapane KL; Hughes CM
    Consult Pharm; 2006 Dec; 21(12):981-7. PubMed ID: 17243849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and implementation of pharmaceutical care planning software for nursing homes based on the Fleetwood Model.
    Lapane KL; Hiris J; Hughes CM; Feinberg J
    Am J Health Syst Pharm; 2006 Dec; 63(24):2483-7. PubMed ID: 17158696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy interventions undertaken by pharmacists in the Fleetwood phase III study: the role of process control.
    Lapane KL; Hughes CM
    Ann Pharmacother; 2006 Sep; 40(9):1522-6. PubMed ID: 16882872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline job satisfaction and stress among pharmacists and pharmacy technicians participating in the Fleetwood Phase III Study.
    Lapane KL; Hughes CM
    Consult Pharm; 2004 Nov; 19(11):1029-37. PubMed ID: 16553486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the fleetwood model of long-term care pharmacy.
    Lapane KL; Hughes CM; Christian JB; Daiello LA; Cameron KA; Feinberg J
    J Am Med Dir Assoc; 2011 Jun; 12(5):355-63. PubMed ID: 21450170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternatives for potentially inappropriate medications in the elderly population: treatment algorithms for use in the Fleetwood Phase III Study.
    Christian JB; Vanhaaren A; Cameron KA; Lapane KL
    Consult Pharm; 2004 Nov; 19(11):1011-28. PubMed ID: 16553485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a United States pharmaceutical care model for nursing homes in the United Kingdom.
    Patterson SM; Hughes CM; Lapane KL
    Pharm World Sci; 2007 Oct; 29(5):517-25. PubMed ID: 17605087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consultant pharmacists and the survey process.
    McSpadden CS
    Consult Pharm; 2006 Jul; 21(7):556-60. PubMed ID: 16934008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the state operations manual: implications for consultant pharmacy practice.
    Martin CM; McSpadden CS
    Consult Pharm; 2006 Dec; 21(12):948-61. PubMed ID: 17243847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gap analysis: assessing the value perception of consultant pharmacist services and the performance of consultant pharmacists.
    Clark TR
    Consult Pharm; 2008 Sep; 23 Suppl C():3-15. PubMed ID: 19032018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing medication-related problems among older Americans.
    Cameron KA
    Manag Care Interface; 1998 Oct; 11(10):74-6, 78, 83-5. PubMed ID: 10186010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions and current state of drug regimen review in nursing facilities: need for a change?
    Bain KT
    Consult Pharm; 2007 Jul; 22(7):586-92. PubMed ID: 17714003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived value and priorities for nursing facility staff training from consultant pharmacists.
    Clark TR
    Consult Pharm; 2008 Sep; 23 Suppl C():16-8. PubMed ID: 19032019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Perceptions of Consultant Pharmacist Services Associated with an Intervention for Adverse Drug Events in the Nursing Facility.
    Kane-Gill SL; Hanlon JT; Fine MJ; Perera S; Culley CM; Studenski SA; Nace DA; Boyce RD; Castle NG; Handler SM
    Consult Pharm; 2016 Dec; 31(12):708-720. PubMed ID: 28074750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacists' interventions for optimization of medication use in nursing homes : a systematic review.
    Verrue CL; Petrovic M; Mehuys E; Remon JP; Vander Stichele R
    Drugs Aging; 2009; 26(1):37-49. PubMed ID: 19102513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Customer assessment of long-term care pharmacy provider services.
    Clark TR
    Consult Pharm; 2008 Sep; 23 Suppl C():19-21. PubMed ID: 19032020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The consultant pharmacist and the physician in the nursing home: roles, relationships, and a recipe for success.
    Levenson SA; Saffel D
    Consult Pharm; 2007 Jan; 22(1):71-82. PubMed ID: 17367254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial oversight of medication use: an expanded role for consultant pharmacists.
    Stefanacci RG
    Consult Pharm; 2012 Apr; 27(4):290-5. PubMed ID: 22498989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of an automated dispensing system in outpatient pharmacies.
    Humphries TL; Delate T; Helling DK; Richardson B
    J Am Pharm Assoc (2003); 2008; 48(6):774-9. PubMed ID: 19019807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.